<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.1 20050630//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id><journal-title>Nucleic Acids Research</journal-title><issn pub-type="ppub">0305-1048</issn><issn pub-type="epub">1362-4962</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>Oxford, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">gkh213</article-id><article-id pub-id-type="doi">10.1093/nar/gkh213</article-id><article-id pub-id-type="pmid">14729924</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Nucleotide incorporation by human DNA polymerase &#x003b3; opposite benzo&#x0005b;<italic>a</italic>&#x0005d;pyrene and benzo&#x0005b;<italic>c</italic>&#x0005d;phenanthrene diol epoxide adducts of deoxyguanosine and deoxyadenosine</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Graziewicz</surname><given-names>Maria A.</given-names></name><xref ref-type="author-notes" rid="gkh213fn2">a</xref></contrib><contrib contrib-type="author"><name><surname>Sayer</surname><given-names>Jane M.</given-names></name><xref ref-type="aff" rid="N0x98264f8.0x9d2cc40">1</xref></contrib><contrib contrib-type="author"><name><surname>Jerina</surname><given-names>Donald M.</given-names></name><xref ref-type="aff" rid="N0x98264f8.0x9d2cc40">1</xref></contrib><contrib contrib-type="author"><name><surname>Copeland</surname><given-names>William C.</given-names></name><xref ref-type="author-notes" rid="gkh213fn1">&#x0002a;</xref></contrib></contrib-group><aff id="N0x98264f8.0x9d2cc40">Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, National Institutes of Health, DHHS, PO Box 12233, Research Triangle Park, NC 27709, USA and <label>1</label>Laboratory of Bioorganic Chemistry, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, DHHS, Bethesda, MD 20892, USA </aff><author-notes><fn id="gkh213fn1"><label>&#x0002a;</label><p>To whom correspondence should be addressed. Tel: &#x0002b;1 919 541 4792; Fax: &#x0002b;1 919 541 7613; Email: <email>copelan1@niehs.nih.gov</email></p></fn><fn id="gkh213fn2"><label>a</label><p>Permanent address: Maria A. Graziewicz, Institute of Biochemistry and Biophysics, Polish Academy of Science, 02-106 Warsaw, Poland</p></fn></author-notes><pub-date pub-type="ppub"><year>2004</year></pub-date><pub-date pub-type="epub"><day>16</day><month>1</month><year>2004</year></pub-date><volume>32</volume><issue>1</issue><fpage>397</fpage><lpage>405</lpage><ext-link ext-link-type="uri" xlink:href="http://www.nar.oupjournals.org/content/vol32/issue1//"/><history><date date-type="received"><day>22</day><month>9</month><year>2003</year></date><date date-type="rev-recd"><day>15</day><month>12</month><year>2003</year></date><date date-type="accepted"><day>15</day><month>12</month><year>2003</year></date></history><copyright-statement>Copyright &#x000a9; 2004 Oxford University Press</copyright-statement><copyright-year>2004</copyright-year><abstract><p>Mitochondria are major cellular targets of benzo&#x0005b;<italic>a</italic>&#x0005d;pyrene (BaP), a known carcinogen that also inhibits mitochondrial proliferation. Here, we report for the first time the effect of site-specific <italic>N</italic><sup>2</sup>-deoxyguanosine (dG) and <italic>N</italic><sup>6</sup>-deoxyadenosine (dA) adducts derived from BaP 7,8-diol 9,10-epoxide (BaP DE) and dA adducts from benzo&#x0005b;<italic>c</italic>&#x0005d;phenanthrene 3,4-diol 1,2-epoxide (BcPh DE) on DNA replication by exonuclease-deficient human mitochondrial DNA polymerase (pol &#x003b3;&#x00029; with and without the p55 processivity subunit. The catalytic subunit alone primarily misincorporated dAMP and dGMP opposite the BaP DE&#x02013;dG adducts, and incorporated the correct dTMP as well as the incorrect dAMP opposite the DE&#x02013;dA adducts derived from both BaP and BcPh. In the presence of p55 the polymerase incorporated all four nucleotides and catalyzed limited translesion synthesis past BaP DE&#x02013;dG adducts but not past BaP or BcPh DE&#x02013;dA adducts. Thus, all these adducts cause erroneous purine incorporation and significant blockage of further primer elongation. Purine misincorporation by pol &#x003b3; opposite the BaP DE&#x02013;dG adducts resembles that observed with the Y family pol &#x003b7;. Blockage of translesion synthesis by these DE adducts is consistent with known BaP inhibition of mitochondrial (mt)DNA synthesis and suggests that continued exposure to BaP reduces mtDNA copy number, increasing the opportunity for repopulation with pre-existing mutant mtDNA and a resultant risk of mitochondrial genetic diseases.</p></abstract></article-meta></front><body><sec><title>INTRODUCTION</title><p>Polycyclic aromatic hydrocarbons (PAHs), many of which are carcinogenic, are widespread environmental contaminants produced by incomplete combustion. Mammalian metabolism of carcinogenic PAHs mediated by cytochromes P450 and epoxide hydrolase generates, among other metabolites, bay region diol epoxides (DE). The tumorigenic potential of these metabolites (<xref ref-type="bibr" rid="gkh213c1">1</xref>) most likely results from their reaction with cellular DNA to form miscoding adducts. Two diastereomers of a given bay region DE are metabolically possible, one in which the benzylic hydroxyl group and the epoxide oxygen are <italic>cis</italic> and one in which these two groups are <italic>trans</italic>. In addition, each of these diastereomers exists as a pair of enantiomers. In the present study, only DNA adducts derived from the pair of enantiomers of the DE diastereomer with the <italic>trans</italic> orientation of the benzylic hydroxyl and epoxide oxygen (Fig. <xref ref-type="fig" rid="gkh213f1">1</xref>A) are used. Of the metabolically possible DEs from a given hydrocarbon, the (<italic>R</italic>,<italic>S</italic>,<italic>S</italic>,<italic>R</italic>)-DE (Fig. <xref ref-type="fig" rid="gkh213f1">1</xref>A) is both metabolically predominant and the most carcinogenic (<xref ref-type="bibr" rid="gkh213c2">2</xref>&#x02013;<xref ref-type="bibr" rid="gkh213c4">4</xref>). The principal sites of DNA adduct formation are at the exocyclic <italic>N</italic><sup>2</sup> and <italic>N</italic><sup>6</sup> amino groups of deoxyguanosine (dG) and deoxyadenosine (dA), respectively (<xref ref-type="bibr" rid="gkh213c5">5</xref>). PAH DE adducts in DNA induce mutations in both mammalian cells (<xref ref-type="bibr" rid="gkh213c6">6</xref>&#x02013;<xref ref-type="bibr" rid="gkh213c8">8</xref>) and bacteria (<xref ref-type="bibr" rid="gkh213c6">6</xref>,<xref ref-type="bibr" rid="gkh213c7">7</xref>,<xref ref-type="bibr" rid="gkh213c9">9</xref>,<xref ref-type="bibr" rid="gkh213c10">10</xref>), thus providing an attractive mechanism for the initiation of cell transformation.</p><p>Mitochondrial DNA (mtDNA) has long been suspected to be a major cellular target of chemical carcinogens (<xref ref-type="bibr" rid="gkh213c11">11</xref>&#x02013;<xref ref-type="bibr" rid="gkh213c19">19</xref>). Benzo&#x0005b;<italic>a</italic>&#x0005d;pyrene (BaP) has been found to localize specifically in mitochondria (<xref ref-type="bibr" rid="gkh213c13">13</xref>). Several studies have demonstrated that mtDNA suffers more modification than nuclear DNA after exposure of cells to BaP or BaP DE (<xref ref-type="bibr" rid="gkh213c11">11</xref>,<xref ref-type="bibr" rid="gkh213c20">20</xref>). In isolated, whole mitochondria from BaP-treated rats, DNA synthesis is reduced but mitochondrial DNA polymerase activity increases, most likely as a feedback response to the high degree of mtDNA modification and decrease in ATP production (<xref ref-type="bibr" rid="gkh213c16">16</xref>). Treatment of cells with BaP inhibits mitochondrial DNA synthesis with the associated presence of 4&#x02013;15 times more adducts per unit length of mtDNA than nuclear DNA (<xref ref-type="bibr" rid="gkh213c21">21</xref>). Recently, using a highly sensitive chemiluminescence immunoassay, levels of BaP DE adducts at dG were found to be 10-fold higher in mtDNA than nuclear DNA per unit length of DNA (<xref ref-type="bibr" rid="gkh213c22">22</xref>). Antioxidant anticancer treatment with <italic>N</italic>-acetylcysteine decreased the amount of mtDNA adducts in rats exposed to cigarette smoke (<xref ref-type="bibr" rid="gkh213c23">23</xref>), which contains PAH carcinogens, possibly by trapping the reactive DE metabolites. Thus, PAHs may exert a more profound effect in the cell on mtDNA relative to nuclear DNA. This may be due to the lipophilic character of these PAHs and the high ratio of lipid to DNA in mitochondria.</p><p>Mitochondrial DNA is replicated by an assembly of proteins and enzymes consisting of polymerase (pol) &#x003b3;, single-stranded DNA binding protein, DNA helicase and a number of accessory proteins and transcription factors (<xref ref-type="bibr" rid="gkh213c24">24</xref>,<xref ref-type="bibr" rid="gkh213c25">25</xref>). In humans, pol &#x003b3; consists of two subunits, a 140 kDa catalytic subunit containing DNA polymerase, exonucleolytic proofreading and dRP lyase activities and a smaller 55 kDa subunit that is a processivity factor with the ability to bind double-stranded DNA (<xref ref-type="bibr" rid="gkh213c26">26</xref>&#x02013;<xref ref-type="bibr" rid="gkh213c28">28</xref>).</p><p>In the present study, translesion synthesis on DNA templates containing BaP or benzo&#x0005b;<italic>c</italic>&#x0005d;phenanthrene (BcPh) DE adducts by human recombinant pol &#x003b3; was examined. We used oligonucleotide substrates, one in which a guanine (G) is modified and the other in which an adenosine (A) is modified, which had previously been examined in both mutagenesis (<xref ref-type="bibr" rid="gkh213c9">9</xref>) and polymerase bypass (<xref ref-type="bibr" rid="gkh213c29">29</xref>,<xref ref-type="bibr" rid="gkh213c30">30</xref>) studies. The human pol &#x003b3; was able to incorporate correct and incorrect nucleotides opposite most of these adducts. The BaP and BcPh adducts caused significant blockage of replication with limited translesion synthesis past certain stereoisomers.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Enzymes</title><p>The exonuclease-deficient form of human DNA pol &#x003b3; (Exo<sup>&#x02013;</sup>p140) was purified to homogeneity from baculovirus-infected insect cells as described (<xref ref-type="bibr" rid="gkh213c26">26</xref>). The recombinant human accessory subunit (p55) was purified to homogeneity from <italic>Escherichia coli</italic> and the heterodimeric forms of the polymerase were reconstituted as previously described (<xref ref-type="bibr" rid="gkh213c28">28</xref>).</p></sec><sec><title>Oligonucleotides</title><p>The <bold>G&#x0002a;</bold> templates containing a single <italic>trans</italic>-opened BaP DE <italic>trans R</italic> or <italic>trans S</italic> dG adduct (Fig. <xref ref-type="fig" rid="gkh213f1">1</xref>A) on the fourth nucleotide from 5&#x02032;-end in the sequence context 5&#x02032;-TTC<bold>G&#x0002a;</bold>AATCC TTCCCCC-3&#x02032; (Fig. <xref ref-type="fig" rid="gkh213f1">1</xref>B) were synthesized as described previously (<xref ref-type="bibr" rid="gkh213c31">31</xref>,<xref ref-type="bibr" rid="gkh213c32">32</xref>). <bold>A&#x0002a;</bold> templates containing dA adducts (Fig. <xref ref-type="fig" rid="gkh213f1">1</xref>A), also on the fourth nucleotide from the 5&#x02032;-end, in the sequence context 5&#x02032;-CAG<bold>A&#x0002a;</bold>TTTAGAGTCTGC-3&#x02032; (Fig. <xref ref-type="fig" rid="gkh213f1">1</xref>B) were synthesized as described: <italic>trans</italic>-opened BaP DE <italic>trans R</italic> or <italic>trans S</italic> dA adducts (<xref ref-type="bibr" rid="gkh213c33">33</xref>), <italic>cis</italic>-opened BaP DE <italic>cis R</italic> or <italic>cis S</italic> dA adducts (<xref ref-type="bibr" rid="gkh213c34">34</xref>) and <italic>cis</italic>-opened BcPh <italic>cis R</italic> or <italic>cis S</italic> dA adducts (<xref ref-type="bibr" rid="gkh213c35">35</xref>). All other oligonucleotides were purchased from Invitrogen Life Technologies, desalted and PAGE purified. The dG primer (5&#x02032;-TCG ATC GAT CCA GGG GGA AGG A-3&#x02032;) for the <bold>G&#x0002a;</bold> templates was gel purified and labeled at the 5&#x02032;-end with &#x0005b;&#x003b3;-<sup>32</sup>P&#x0005d;ATP by T4 polynucleotide kinase (<xref ref-type="bibr" rid="gkh213c36">36</xref>). The dG primer, the <bold>G&#x0002a;</bold> template containing either the BaP <italic>trans R</italic> or <italic>trans S</italic> dG adduct and a 12mer (5&#x02032;-TGG ATC GAT CGA-3&#x02032;) were annealed in a 1:1.4:1.4 ratio to produce the substrate in Figure <xref ref-type="fig" rid="gkh213f1">1</xref>B. To construct substrates of suitable length, each adducted 16mer template and an additional 12mer were annealed to a 22mer primer (see Fig. <xref ref-type="fig" rid="gkh213f1">1</xref>B). Annealing was performed by heating the oligonucleotides to 90&#x000b0;C for 5 min followed by slow cooling to room temperature in 10 mM Tris&#x02013;HCl, pH 7.5. Likewise, the dA primer (5&#x02032;-TCG ATC GAT CCA GCA GAC TCT A-3&#x02032;) for the <bold>A&#x0002a;</bold> templates was gel purified and labeled at the 5&#x02032;-end with &#x0005b;&#x003b3;-<sup>32</sup>P&#x0005d;ATP by T4 polynucleotide kinase. As above, the dA primer, each of the <bold>A&#x0002a;</bold> templates and the 12mer (5&#x02032;-TGG ATC GAT CGA-3&#x02032;) were annealed in a 1:1.4:1.4 ratio to produce the substrates in Figure <xref ref-type="fig" rid="gkh213f1">1</xref>B. Control reactions for each set contained identical oligonucleotides except that the 16mer templates contained a normal dA or dG residue in place of the adducts.</p></sec><sec><title>DNA polymerase reactions</title><p>DNA pol &#x003b3; reactions (10 &#x000b5;l final volume) contained final concentrations of 25 mM HEPES&#x02013;KOH (pH 7.5), 5 mM MgCl<sub>2</sub>, various concentrations of the four dNTPs, 2 mM 2-mercaptoethanol, 50 &#x000b5;g/ml bovine serum albumin, 0.1 mM EDTA, 1 pmol 5&#x02032;-<sup>32</sup>P-labeled 22mer previously annealed to 1.4 pmol 16mer template and 1.4 pmol 12mer (Fig. <xref ref-type="fig" rid="gkh213f1">1</xref>B). Reactions were started by addition of DNA pol &#x003b3; (10 fmol for control substrates and 60 fmol for adducted substrates), either Exo<sup>&#x02013;</sup>p140 alone or in complex with the accessory subunit (1.0:1.1 molar ratio). Samples were incubated for 5 min at 37&#x000b0;C. Reactions were stopped by addition of 10 &#x000b5;l of 95&#x00025; aqueous formamide containing 25 mM EDTA and gel sequencing dye solution, followed by brief heating in a boiling water bath.</p></sec><sec><title>Incorporation analysis</title><p>Reaction products (4 &#x000b5;l) were loaded onto 15&#x00025; polyacrylamide gels containing 7 M urea. Following electrophoresis, the gels were dried, exposed to a PhosphorImager screen and analyzed in a Storm 860 PhosphorImager (Molecular Dynamics). Radioactive bands were quantified with NIH Image software (version 1.62). <italic>V</italic><sub>max</sub> and <italic>K</italic><sub>m</sub> values were calculated using a non-linear Michaelis&#x02013;Menten kinetic fit program from M.F. Goodman (USC). Misincorporation efficiencies were calculated from relative <italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub> values.</p></sec></sec><sec><title>RESULTS</title><p>Human mitochondrial DNA pol &#x003b3; has been tested for its ability to catalyze extension bypass of dG and dA adducts derived from two PAHs, as well as the specificity of nucleotide insertion opposite them using 22mer primer/28mer template complexes (see Materials and Methods). Structures of the adducts studied are shown in Figure <xref ref-type="fig" rid="gkh213f1">1</xref>A. These adducts are the BaP <italic>trans R</italic> and <italic>trans S</italic> dG adducts (in <bold>G&#x0002a;</bold> template&#x02013;primer sets; Fig. <xref ref-type="fig" rid="gkh213f1">1</xref>B), the BaP <italic>trans R</italic>, <italic>trans S</italic>, <italic>cis R</italic> and <italic>cis S</italic> dA adducts and the BcPh <italic>cis S</italic> and <italic>cis R</italic> dA adducts (in <bold>A&#x0002a;</bold> template&#x02013;primer sets). These adducts were copied by the exonuclease-deficient form of pol &#x003b3; (Exo<sup>&#x02013;</sup>p140) alone as well as in the complex with the pol &#x003b3; accessory subunit, p55.</p><p>We first attempted to extend 10mer oligonucleotide primers annealed to the 16mer adducted and control templates. However, pol &#x003b3; did not extend these short 16/10mer template&#x02013;primers efficiently (&#x0003c;10&#x00025; of primers extended), consistent with a requirement by the enzyme for a longer piece of DNA for optimal binding. We therefore synthesized a longer 22mer primer as well as a 12mer template extension and assembled the oligonucleotides as shown in Figure <xref ref-type="fig" rid="gkh213f1">1</xref>B. These longer template&#x02013;primer sets were &#x0003e;3-fold more efficiently extended compared to the 10mer primers. We performed primer extension reactions with oligonucleotides in a running start reaction to reflect more accurately processive replication. These running start reactions were initiated by synthesis opposite either two T or two A residues in the template with a low concentration (1 &#x000b5;M) of either dATP or dTTP, respectively. The low dose of either dATP or dTTP was supplied to progress the polymerase to the site of the adduct. Incorporation opposite the adduct was tested by addition of each of the nucleoside triphosphates at high concentration. At least 1.0 mM dNTP was needed in order to detect incorporation opposite most of the adducts studied.</p><sec><title>Pol &#x003b3;-dependent replication of two diastereomeric BaP DE&#x02013;dG adducts with and without the pol &#x003b3; accessory subunit</title><p>Translesion synthesis by human pol &#x003b3; with and without the accessory subunit was tested with the <italic>trans R</italic> and <italic>trans S</italic> diastereomers of the BaP DE&#x02013;dG adducts using the first template&#x02013;primer set in Figure <xref ref-type="fig" rid="gkh213f1">1</xref>B. As can be seen in lane 3 in each panel of Figure <xref ref-type="fig" rid="gkh213f2">2</xref>, the low concentration of dTTP was sufficient to fill the 2 nt gap prior to the site of the adduct, but did not cause any further incorporation or misincorporation opposite the adducts or the control template G. Addition of each nucleotide separately at high concentration is depicted in lanes 4&#x02013;7 (Fig. <xref ref-type="fig" rid="gkh213f2">2</xref>A, Exo<sup>&#x02013;</sup> p140 alone). With 1 mM each nucleoside triphosphate, pol &#x003b3; easily incorporated the correct as well as the incorrect nucleotides on the control template. With the isolated catalytic subunit we even observed misincorporation of dGMP and extension of this misincorporation (lane 7 for no lesion), as well as incorrect elongation after a correctly incorporated dCMP residue (lane 6).</p><p>The scenario for the action of pol &#x003b3; on the substrates containing BaP DE&#x02013;dG adducts was quite different. Here, pol &#x003b3; incorporated mainly dAMP opposite the BaP DE adducts (Fig. <xref ref-type="fig" rid="gkh213f2">2</xref>A, lane 4), with a lesser efficiency of dGMP incorporation (Fig. <xref ref-type="fig" rid="gkh213f2">2</xref>A, lane 7). No correct incorporation of dCMP or incorrect incorporation of dTMP opposite these adducts was observed with the p140 subunit. The ability of the polymerase to extend past these adducts was tested by addition of all four dNTPs (lane 2 of each panel). As expected, the polymerase was easily able to extend synthesis to the end of the non-adducted template (Fig. <xref ref-type="fig" rid="gkh213f2">2</xref>A). Addition of all four dNTPs to reactions containing the BaP DE&#x02013;dG adducted templates resulted in incorporation of only a single nucleotide residue opposite the adduct, similar to the results observed with either dGTP or dATP alone. Thus, the isolated catalytic subunit misincorporated either a dGMP or dAMP opposite the <italic>trans R</italic> and <italic>trans S</italic> adducts but could not extend these products.</p><p>Addition of the accessory p55 subunit (Fig. <xref ref-type="fig" rid="gkh213f2">2</xref>B) caused the polymerase to synthesize more product with the non-adducted template as well as with the BaP <italic>trans R</italic> and <italic>trans S</italic> dG adducted templates. With all four nucleotides present, pol &#x003b3; with the accessory subunit inserted one or more nucleotides past the end of the template, most likely through a template dislocation intermediate or strand slippage mechanism that we previously documented for pol &#x003b3; (<xref ref-type="bibr" rid="gkh213c37">37</xref>). The Exo<sup>&#x02013;</sup> p140/p55 complex was able to incorporate all four nucleotides and extended past the resulting (mis)pair by at least one additional dAMP, dCMP or dGMP nucleotide on the control template with 1 mM each dNTP. With the BaP dG adducts, the p55 accessory subunit caused the polymerase to incorporate all of the nucleotides opposite the BaP DE&#x02013;dG adducts, as compared to just dGMP or dAMP incorporation with the isolated catalytic subunit. In addition, a 1 nt translesion extension was observed with either 1 mM dATP or dGTP (Fig. <xref ref-type="fig" rid="gkh213f2">2</xref>B, lanes 4 and 7, arrow). In the presence of all four dNTPs (lane 2), the presence of p55 resulted in the 1 nt extension observed with either dATP or dGTP alone but failed to cause further extension.</p></sec><sec><title>Pol &#x003b3;-dependent replication of four diastereomeric BaP DE&#x02013;dA adducts with and without the pol &#x003b3; accessory subunit</title><p>Translesion synthesis opposite BaP <italic>trans S</italic>, BaP <italic>trans R</italic>, BaP <italic>cis S</italic> and BaP <italic>cis R</italic> dA adducts was tested in a different sequence context, using the running start <bold>A&#x0002a;</bold> template&#x02013;primer sets shown in Figure <xref ref-type="fig" rid="gkh213f1">1</xref>B. In these template&#x02013;primer sets a low concentration of dATP was required to progress the polymerase to the site of the adduct in a processive synthesis. With the control template no significant amount of misincorporation of 1 &#x000b5;M dAMP by either the catalytic subunit alone or the complex containing the accessory subunit was observed (Fig. <xref ref-type="fig" rid="gkh213f3">3</xref>A and B, control template, lanes 3). With the addition of each of the four nucleoside triphosphates at high concentration (1 mM) to the control template we observed not only incorporation of the cognate dTMP into the primer but also the misincorporation of dAMP and dCMP. In addition extension of the A-C mispair by correct incorporation of dCMP opposite the next G was observed. Complete extension was observed when high concentrations of all four dNTPs were present. Qualitatively, the results were the same with and without the accessory subunit present.</p><p>With the higher amount of pol &#x003b3; needed to detect incorporation opposite the BaP DE&#x02013;dA adduct we observed a slight amount of dAMP incorporation in the presence of the low 1 &#x000b5;M dATP needed to progress the polymerase to the site of the adduct. This amount of misincorporation with 1 &#x000b5;M dATP varied depending on adduct stereochemistry, but was generally low enough not to interfere with interpretation of the incorporation of the other nucleotides. In the presence of 1 mM dATP this misincorporation of dAMP opposite all four of the adducts was significantly increased. At high concentration the only other nucleotide to show significant incorporation relative to the background of dAMP was the cognate dTMP in the case of the BaP <italic>trans R</italic> and <italic>trans S</italic> dA adducts, while no significant dTMP incorporation was observed with the BaP <italic>cis</italic> R and <italic>cis S</italic> dA adducts. No dCMP or dGMP incorporation was observed with any of the BaP dA adducts. With all four nucleotides present only trace amounts of extension were observed on the BaP <italic>trans R</italic> and <italic>trans S</italic> dA templates and extension was not detected on the BaP <italic>cis R</italic> and <italic>cis S</italic> dA templates.</p><p>Upon addition of the p55 accessory subunit to these reactions, we observed enhanced incorporation with all of the BaP DE&#x02013;dA adducts. The accessory subunit allowed correct incorporation of dTMP opposite the BaP <italic>trans R</italic> and <italic>trans S</italic> dA adducts, to about the same extent as the misincorporation of dA. There was no evidence for enhanced misincorporation of dCMP or dGMP opposite the <italic>trans</italic> adducts, since these bands (Fig. <xref ref-type="fig" rid="gkh213f3">3</xref>B) were the same as those observed with 1 &#x000b5;M dATP alone. The situation with the BaP <italic>cis R</italic> and <italic>cis S</italic> dA adducted templates was very different in the presence of the accessory subunit. Here, we observed primarily dAMP misincorporation as well as slight incorporation of dCMP and possibly dGMP, which were not observed in the absence of the p55 subunit. There was little or no enhanced incorporation of dTMP opposite the adduct in the presence of the accessory subunit. Thus the effect of the accessory subunit on incorporation opposite BaP DE&#x02013;dA adducts varies with the stereoisomer.</p></sec><sec><title>Pol &#x003b3;-dependent replication of two stereoisomeric BcPh DE&#x02013;dA adducts with and without the pol &#x003b3; accessory subunit</title><p>Incorporation and translesion synthesis on a running start template having the same sequence as that used with the BaP dA adducts (Fig. <xref ref-type="fig" rid="gkh213f1">1</xref>B) were also examined with BcPh <italic>cis R</italic> and <italic>cis S</italic> dA adducts. The incorporation by pol &#x003b3; with and without the accessory subunit on the non-adducted template is shown as the control in Figure <xref ref-type="fig" rid="gkh213f4">4</xref>A and B, respectively. With the catalytic subunit alone, dAMP was the only nucleotide incorporated opposite either diastereomeric BcPh dA adduct, with more dAMP being misincorporated opposite the <italic>cis S</italic> diastereomer (Fig. <xref ref-type="fig" rid="gkh213f4">4</xref>A, lane 4). In the presence of all four dNTPs, incorporation (presumably of dA) opposite the adduct occurred, but no further translesion synthesis was observed (Fig. <xref ref-type="fig" rid="gkh213f4">4</xref>A, lane 2).</p><p>Addition of the p55 accessory subunit to the BcPh-adducted template reactions allowed nucleotides other than dAMP to be incorporated. With the <italic>cis R</italic> diastereomer, all four nucleotides were incorporated. When all four dNTPs were present together, the pol &#x003b3; complex was able to incorporate a small amount of nucleotide one base past the adduct, but no further extension was detected. With the BcPh <italic>cis S</italic> isomer, dCMP and dGMP but not the cognate dTMP were incorporated by the pol &#x003b3; complex, and no further extension was detected.</p></sec><sec><title>Kinetics of nucleotide insertion opposite BaP and BcPh adducts by pol &#x003b3;</title><p>To determine relative efficiency of incorporation and misincorporation by pol &#x003b3; opposite the adducts, we performed kinetic analysis of primer extension reactions. As in our other experiments, exonuclease-deficient pol &#x003b3; was used to avoid degradation of the primer by the proofreading activity and to simplify interpretation of the results. This strategy was imperative due to the relatively high amounts of enzyme required to detect incorporation opposite the adducts. With the <bold>G&#x0002a;</bold> template&#x02013;primer sets, the running start reaction requires processive DNA synthesis by inserting two dTMPs (I<sub>1</sub> and I<sub>2</sub>) prior to the target <bold>G&#x0002a;</bold> site for the correct or incorrect nucleotide (I<sub>3</sub>). From integration of the intensities of PhosphorImager scans of I<sub>1</sub>, I<sub>2</sub> and I<sub>3</sub>, reaction velocities were determined and misinsertion efficiency (<italic>f</italic><sub>ins</sub>) was calculated as the ratio <italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub> for incorrect and correct nucleotides. Velocity was expressed as the ratio I<sub>3</sub>/I<sub>2</sub> as described (<xref ref-type="bibr" rid="gkh213c38">38</xref>,<xref ref-type="bibr" rid="gkh213c39">39</xref>). The same approach used dATP to accomplish the running start with the <bold>A&#x0002a;</bold> template&#x02013;primer sets (Fig. <xref ref-type="fig" rid="gkh213f1">1</xref>B).</p><p>For the kinetic studies with <bold>G&#x0002a;</bold> template&#x02013;primer sets, the concentration of dTTP required to fill the I<sub>1</sub> and I<sub>2</sub> positions was lowered to minimize the misinsertion of dTMP opposite the dG adduct that we observed in Figure <xref ref-type="fig" rid="gkh213f2">2</xref>. Since incorporation opposite these adducts was very inefficient in the absence of the accessory subunit, only the kinetic parameters for the two-subunit complex are shown. Table <xref ref-type="table" rid="gkh213tb1">1</xref> displays the apparent kinetic parameters for incorporation opposite the BaP <italic>trans S</italic> and <italic>trans R</italic> dG adducts. Steady-state assumptions allow the overall efficiency of each enzyme on a normal DNA template to be estimated as <italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>m(dNTP)</sub>, a parameter comparable to the pre-steady-state indicator of enzymatic efficiency <italic>k</italic><sub>pol</sub>/<italic>K</italic><sub>d(dNTP)</sub> (<xref ref-type="bibr" rid="gkh213c40">40</xref>,<xref ref-type="bibr" rid="gkh213c41">41</xref>). With saturating template&#x02013;primer concentrations the ratio <italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>m(dNTP)</sub> does not change upon restriction of DNA synthesis (<xref ref-type="bibr" rid="gkh213c42">42</xref>), which is encountered by replication opposite damaged template bases, and <italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>m(dNTP)</sub> remains a valid parameter for comparing insertion events by pol &#x003b3;. Similarly, since steady-state parameters do not account for the expected differences in <italic>K</italic><sub>d(dNTP)</sub> with normal or damaged templates, comparisons of differential insertion by a given enzyme are best described as <italic>f</italic><sub>ins</sub> &#x0003d; (<italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub>)<sub>incorrect</sub>/(<italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub>)<sub>correct</sub>.</p><p>Individual kinetic parameters are presented in the tables as <italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m(dNTP)</sub> ratios and <italic>f</italic><sub>ins</sub> values. The kinetic values for the BaP <italic>trans R</italic> and <italic>trans S</italic> dG adducts (Table <xref ref-type="table" rid="gkh213tb1">1</xref>) corroborate the observations in Figure <xref ref-type="fig" rid="gkh213f2">2</xref>. Although fidelity of the exonuclease-deficient pol &#x003b3; in the presence of the p55 accessory subunit on the non-adducted dG substrate was low, presumably due to the effects of the accessory subunit, the correct dCMP was still much more effectively inserted opposite a normal dG base than opposite either of the adducts. Incorporation of dCMP opposite either dG adduct was 200 000- to 400 000-fold less efficient than dCMP incorporation opposite the non-adducted template dG bases (compare <italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub> values between the non-adducted template and BaP-adducted templates). In fact, dCMP was the worst nucleotide incorporated, while dAMP and dGMP were most efficiently incorporated opposite the BaP dG adducts. The <italic>f</italic><sub>ins</sub> values indicate that dAMP was incorporated 4.3 to 4.7 times more readily than dCMP on the adducted templates, whereas dAMP was incorporated 100-fold less efficiently than dCMP on the non-adducted template. Pol &#x003b3; showed little difference in incorporation efficiency of each nucleotide between the <italic>trans R</italic> and <italic>trans S</italic> isomers of the BaP DE&#x02013;dG adducts (Table <xref ref-type="table" rid="gkh213tb1">1</xref>).</p><p>In contrast, the kinetics of nucleotide incorporation opposite the BaP DE&#x02013;dA adducts by pol &#x003b3; clearly revealed differences between the adduct stereoisomers (Table <xref ref-type="table" rid="gkh213tb2">2</xref>), especially in incorporation of dGMP and dCMP between the <italic>cis</italic> and <italic>trans</italic> adducts. With either the BaP <italic>trans R</italic> or <italic>trans S</italic> dA adduct we observed no detectable (&#x0003e;1&#x00025; extended product) incorporation of dGMP or dCMP, whereas with either the <italic>cis R</italic> or <italic>cis S</italic> dA adduct we could readily detect and quantify the level of dGMP and dCMP incorporation. However, there was little difference between the BaP <italic>cis R</italic> and <italic>cis S</italic> dA adducts or between the BaP <italic>trans R</italic> and <italic>trans S</italic> dA adducts. Incorporation of the cognate dTMP opposite the BaP DE&#x02013;dA adducts was between 7500- and 41 000-fold less efficient than dTMP incorporation on the non-adducted template. Incorrect dAMP was the most efficiently incorporated nucleotide opposite all four of the isomeric BaP DE&#x02013;dA adducts, although its incorporation was still less efficient than that for dAMP misincorporation opposite the non-adducted dA template. As in the case of the dG adducts, incorporation of the correct nucleotide was more seriously hindered by an adduct than incorporation of an erroneous dAMP, resulting in increased misincorporation frequencies opposite the adducts.</p><p>Incorporation opposite the BcPh <italic>cis R</italic> and <italic>cis S</italic> dA adducts (Fig. <xref ref-type="fig" rid="gkh213f1">1</xref>) was detected with each of the four dNTPs (Table <xref ref-type="table" rid="gkh213tb3">3</xref>). <italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub> ratios were quite similar for the BcPh <italic>cis</italic> dA adducts and their corresponding BaP analogs (within a factor of &#x0223c;3 or less except for dTMP incorporation opposite the BcPh <italic>cis R</italic> adduct, which was 6 times less efficient than opposite the corresponding BaP <italic>cis R</italic> adduct). Incorporation of the cognate dTMP was 106 000- and 41 000-fold less efficient on the BcPh <italic>cis R</italic> and <italic>cis S</italic> dA templates as compared to the non-adducted dA template, whereas misincorporation of dAMP on both BcPh templates was only 6- to 8-fold less efficient than dAMP misincorporation on the non-adducted control template. Incorrect dAMP was 40- and 9-fold more likely to be incorporated on the BcPh <italic>cis R</italic> and <italic>cis S</italic> templates, respectively, as compared to dTMP. This was in contrast to the control template, where dAMP is incorporated more than 300 times less efficiently than dTMP by pol &#x003b3;. Among all the adduct-templated (mis)incorporations measured in this study, misincorporations of dAMP opposite the BcPh and BaP <italic>cis</italic> dA adducts were most efficient.</p></sec></sec><sec><title>DISCUSSION</title><p>Reports of translesion synthesis past DNA adducts by pol &#x003b3; are limited. The ability of pol &#x003b3; to synthesize past abasic sites has been studied, and the enzyme was found to stall the majority of the time (<xref ref-type="bibr" rid="gkh213c43">43</xref>). When pol &#x003b3; does perform translesion synthesis past an abasic site, it prefers to incorporate dAMP opposite the site (<xref ref-type="bibr" rid="gkh213c43">43</xref>). Translesion synthesis by pol &#x003b3; is readily accomplished opposite 7,8-dihydro-8-oxo-2&#x02032;-deoxyguanosine (8-oxo-dG) template bases. <italic>Xenopus laevis</italic> pol &#x003b3; incorporates dCMP 73&#x00025; of the time while misincorporating dAMP 27&#x00025; of the time opposite an 8-oxo-dG adduct (<xref ref-type="bibr" rid="gkh213c43">43</xref>). Translesion DNA synthesis past Pt&#x02013;DNA adducts by human mitochondrial DNA polymerase has been demonstrated (<xref ref-type="bibr" rid="gkh213c44">44</xref>). Human pol &#x003b3; displays a specificity for translesion synthesis past dien Pt&#x02013;DNA adducts, with less synthesis past oxaliplatin and still less for cisplatin (<xref ref-type="bibr" rid="gkh213c44">44</xref>). While damage to mtDNA by BaP is well established (<xref ref-type="bibr" rid="gkh213c11">11</xref>,<xref ref-type="bibr" rid="gkh213c20">20</xref>&#x02013;<xref ref-type="bibr" rid="gkh213c23">23</xref>,<xref ref-type="bibr" rid="gkh213c45">45</xref>), translesion synthesis past BaP adducts by pol &#x003b3; has not previously been investigated. Here we have studied base incorporation and translesion synthesis opposite BaP DE&#x02013;dG, BaP DE&#x02013;dA and BcPh DE&#x02013;dA adducts in DNA by human mitochondrial DNA polymerase with and without the p55 accessory subunit.</p><p>The catalytic subunit alone had weak ability to incorporate opposite all of the DE adducts studied and showed no translesion synthesis. Even in the presence of the p55 accessory subunit we observed only limited, one base extension beyond the BaP DE&#x02013;dG adducts, and even weaker extension or no extension at all beyond dA adducts. For all the adducts studied, kinetics experiments in the presence of p55 indicated that the total incorporation of both correct and incorrect nucleotides opposite these adducts was decreased by 3&#x02013;4 orders of magnitude relative to the unmodified control template. Thus these adducts present a substantial block to DNA replication <italic>in vitro</italic>. This blockage is consistent with the inhibition of mtDNA replication that was previously demonstrated with intact mitochondria upon treatment with BaP (<xref ref-type="bibr" rid="gkh213c16">16</xref>,<xref ref-type="bibr" rid="gkh213c21">21</xref>).</p><p>Pol &#x003b3; containing its associated 3&#x02032;&#x02192;5&#x02032; proofreading exonuclease activity is highly accurate (<xref ref-type="bibr" rid="gkh213c37">37</xref>). The present study required use of exonuclease-deficient pol &#x003b3; in order to avoid degradation of the primers, resulting in markedly reduced fidelity of replication for unmodified DNA. However, even in the absence of proofreading ability, pol &#x003b3; still inserted predominantly the correct nucleotide opposite a normal dG or dA, with an error frequency of &#x0003c;10<sup>&#x02013;3</sup> for most cases. In contrast, pol &#x003b3; with its accessory subunit incorporated all three incorrect nucleotides in preference to the correct dCMP opposite dG adducts. The nucleotides most frequently inserted opposite a dG adduct were the purine nucleotides dGMP and dAMP, with <italic>f</italic><sub>ins</sub> values of 3.7&#x02013;4.7 for both nucleotides. This was a consequence of a dramatically reduced incorporation of the correct dCMP along with much smaller decreases in incorporation of the incorrect nucleotides. A similar effect was observed with the dA-adducted templates, with dAMP being incorporated in preference to the correct dTMP opposite all the dA adducts studied.</p><p>Pol &#x003b3; is a family A DNA polymerase which includes such well-studied DNA polymerases as the <italic>E.coli</italic> pol I and T7 DNA polymerase. Thus, one might expect pol &#x003b3; to exhibit the same pattern of translesion bypass with BaP DE adducts as <italic>E.coli</italic> pol I and T7 DNA polymerase. Studies with the Sequenase 2.0 version of T7 DNA polymerase demonstrated that BaP DE&#x02013;dG adducts blocked base insertion opposite the adducts <italic>in vitro</italic> (<xref ref-type="bibr" rid="gkh213c46">46</xref>). On the basis of molecular modeling studies, preferential dAMP insertion opposite a BaP <italic>trans S</italic> dG adduct by the T7 DNA polymerase has been postulated to result from stabilizing interactions between the polymerase, DNA and dATP (<xref ref-type="bibr" rid="gkh213c47">47</xref>). With dA adducts, Sequenase was also shown to be very inefficient at nucleotide incorporation and, like pol &#x003b3;, incorporated mostly an incorrect dAMP opposite both the <italic>trans R</italic> and <italic>trans S</italic> adducts (<xref ref-type="bibr" rid="gkh213c33">33</xref>). The response of A family pol &#x003b3; to adducts is also reminiscent of that of the Y family bypass polymerase &#x003b7;, which showed a strong preference for purine nucleotide misincorporation opposite BaP DE&#x02013;dG adducts (<xref ref-type="bibr" rid="gkh213c30">30</xref>).</p><p>Mutations in mtDNA can induce a multitude of severe metabolic disorders and mitochondrial genetic disorders (<xref ref-type="bibr" rid="gkh213c48">48</xref>). Although translesion synthesis by pol &#x003b3; in the present study was inefficient and was limited to a single base extension beyond BaP DE&#x02013;dG adducts, our observation of enhanced misincorporation opposite the adducts suggests a mechanism for mutagenesis, should pol &#x003b3; be able to replicate past these adducts <italic>in vivo</italic>. Another attractive, although indirect, mechanism exists for delayed phenotypic expression of mutations as a result of DNA damage induced by PAHs. Mitochondrial DNA is a multicopy genome, with as many as 10 000 mtDNA genomes per cell, and can exist in heteroplasmic form in which a low percentage of the genomes may contain mutations, either silent or deleterious. Depending on the tissue type, deleterious mutations in mtDNA can exist below a clinical threshold in which phenotypic symptoms do not show. Increasing the percentage of the genomes which carry such mutations above the respiratory threshold of that tissue causes tissue degeneration and mitochondrial disease. Although BaP damage to mtDNA is well established (<xref ref-type="bibr" rid="gkh213c11">11</xref>,<xref ref-type="bibr" rid="gkh213c20">20</xref>) and later studies have supported this finding (<xref ref-type="bibr" rid="gkh213c21">21</xref>&#x02013;<xref ref-type="bibr" rid="gkh213c23">23</xref>,<xref ref-type="bibr" rid="gkh213c45">45</xref>), long-term mutagenicity of this damage to mtDNA has not been observed (<xref ref-type="bibr" rid="gkh213c49">49</xref>,<xref ref-type="bibr" rid="gkh213c50">50</xref>). This may be due to the fact that most of the adducted mitochondrial genomes cause a complete block in DNA replication and loss of the damaged genomes, consistent with the observation of a decrease in mtDNA replication and mtDNA copy number after BaP treatment without accompanying fixed mutations. Thus, the multicopy nature of mtDNA gives the cell the advantage of dispensing with damaged genomes instead of attempting to repair them. However, blockage of mtDNA replication and subsequent depletion in mtDNA may have another consequence on mtDNA heteroplasmy. Replication of the remaining mitochondrial genomes would amplify any mutations (from whatever source) in this surviving population. Thus, deleterious long-term consequences of adducts from BaP and other PAHs in mtDNA could result from pre-existing mutations which reach a physiologically significant level only after the mtDNA population has been depleted by PAH adduct-related DNA damage.</p></sec></body><back><sec sec-type="display-objects"><title>Figures and Tables</title><fig id="gkh213f1"><label>Figure 1</label><caption><p> (<bold>A</bold>) Structures of the benzo&#x0005b;<italic>a</italic>&#x0005d;pyrene (BaP) and benzo&#x0005b;<italic>c</italic>&#x0005d;phenanthrene (BcPh) diol epoxide (DE) enantiomers (diastereomer with a benzylic hydroxyl group and epoxide oxygen <italic>trans</italic>), as well as their DNA adducts used in this study (dG &#x0003d; dG residue and dA &#x0003d; dA residue with the point of attachment to the hydrocarbon at <italic>N</italic><sup>2</sup> and <italic>N</italic><sup>6</sup>, respectively). Note that the configuration at the benzylic carbon of the epoxide is inverted on <italic>trans</italic> opening of the epoxide and retained on <italic>cis</italic> opening. (<bold>B</bold>) Template&#x02013;primer substrates for pol &#x003b3; with dG and dA adducts at the indicated positions (<bold>G&#x0002a;</bold> and <bold>A&#x0002a;</bold>, respectively). A 12mer complementary to the 5&#x02032;-end of each 22mer primer was annealed to the primer in order to create a substrate with a 22mer primer and a 26mer template containing a gap that does not affect its enzymatic processing. Controls consisted of substrates with the normal (unadducted) bases at positions <bold>G&#x0002a;</bold> and <bold>A&#x0002a;</bold>.</p></caption><graphic xlink:href="gkh213f1"/></fig><fig id="gkh213f2"><label>Figure 2</label><caption><p> Single base insertion opposite normal dG and BaP <italic>trans R</italic> and <italic>trans S</italic> dG adducts in oligonucleotides. Reactions containing either Exo<sup>&#x02013;</sup>p140 (<bold>A</bold>) or Exo<sup>&#x02013;</sup>p140/p55 complex (<bold>B</bold>) were incubated for 5 min at 37&#x000b0;C. A partial sequence of the <bold>G&#x0002a;</bold> templates (Fig. <xref ref-type="fig" rid="gkh213f1">1</xref>B) is shown vertically on both panels of the figure, with the BaP-modified guanine indicated as G&#x0002a;&#x0002a;. Lane 0, no dNTPs added; lane 4, all four dNTPs (each at 1 mM final concentration) added; lane T&#x0002a;, 1 &#x000b5;M dTTP (added to initiate a running start one base before the BaP-adducted guanine, G&#x0002a;&#x0002a;); lanes A, T, C and G, 1 &#x000b5;M dTTP plus 1 mM one of the four dNTPs. The arrow (B) indicates the products of extension past the adduct.</p></caption><graphic xlink:href="gkh213f2"/></fig><fig id="gkh213f3"><label>Figure 3</label><caption><p> Single base insertion opposite normal dA and BaP <italic>trans R</italic>, <italic>cis R</italic>, <italic>trans S</italic> and <italic>cis S</italic> dA adducts in oligonucleotides. Reactions containing either Exo<sup>&#x02013;</sup>p140 (<bold>A</bold>) or Exo<sup>&#x02013;</sup>p140/p55 complex (<bold>B</bold>) were incubated for 5 min at 37&#x000b0;C. A partial sequence of the <bold>A&#x0002a;</bold> templates (Fig. <xref ref-type="fig" rid="gkh213f1">1</xref>B) is shown vertically on both panels of the figure, with the BaP-modified adenine indicated as A&#x0002a;&#x0002a;. Concentrations of the dNTPs and lane designations are as in Figure <xref ref-type="fig" rid="gkh213f3">3</xref>, except that each incubation contained 1 &#x000b5;M dATP to initiate a running start on the <bold>A&#x0002a;</bold> templates.</p></caption><graphic xlink:href="gkh213f3"/></fig><fig id="gkh213f4"><label>Figure 4</label><caption><p> Single base insertion opposite normal dA and BcPh <italic>cis R</italic> and <italic>cis S</italic> dA adducts in oligonucleotides. Reactions containing either Exo<sup>&#x02013;</sup>p140 (<bold>A</bold>) or Exo<sup>&#x02013;</sup>p140/p55 complex (<bold>B</bold>) were incubated for 5 min at 37&#x000b0;C. A partial sequence of the <bold>A&#x0002a;</bold> template is shown vertically on both panels of the figure, with the BcPh-modified adenine indicated as A&#x0002a;&#x0002a;. Concentrations of the dNTPs and lane designations are as in Figure <xref ref-type="fig" rid="gkh213f3">3</xref>.</p></caption><graphic xlink:href="gkh213f4"/></fig><table-wrap id="gkh213tb1"><label>Table 1.</label><caption><title>Kinetics of insertion by the p140/p55 pol &#x003b3; complex opposite the BaP <italic>trans R</italic> and BaP <italic>trans S</italic> dG adducts in the sequence 3&#x02032;-&#x02026;AA<bold>G&#x0002a;</bold>CTT-5&#x02032;</title></caption><table frame="hsides" rules="groups" border="1" width="85%"><colgroup><col/><col/><col/><col/></colgroup><thead valign="bottom"><tr valign="top"><th valign="top">Adduct</th><th valign="top">dNTP</th><th valign="top"><italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub><sup>a</sup></th><th valign="top"><italic>f</italic><sub>ins</sub><sup>b</sup></th></tr></thead><tbody valign="top"><tr valign="top"><td valign="top">None</td><td valign="top">G:dATP</td><td valign="top">3.3</td><td valign="top">1.0 &#x000d7; 10<sup>&#x02013;2</sup></td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">G:dTTP</td><td valign="top">1.5 &#x000d7; 10<sup>&#x02013;2</sup></td><td valign="top">4.8 &#x000d7; 10<sup>&#x02013;5</sup></td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">G:dCTP</td><td valign="top">319</td><td valign="top">1</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">G:dGTP</td><td valign="top">8.2 &#x000d7; 10<sup>&#x02013;2</sup></td><td valign="top">2.6 &#x000d7; 10<sup>&#x02013;3</sup></td></tr><tr valign="top"><td valign="top">BaP <italic>trans R</italic></td><td valign="top">G:dATP</td><td valign="top">3.3 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">4.7</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">G:dTTP</td><td valign="top">1.9 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">2.8</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">G:dCTP</td><td valign="top">7 &#x000d7; 10<sup>&#x02013;4</sup></td><td valign="top">1</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">G:dGTP</td><td valign="top">2.9 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">4.1</td></tr><tr valign="top"><td valign="top">BaP <italic>trans S</italic></td><td valign="top">G:dATP</td><td valign="top">6.8 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">4.3</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">G:dTTP</td><td valign="top">2.3 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">1.4</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">G:dCTP</td><td valign="top">1.6 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">1</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">G:dGTP</td><td valign="top">6 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">3.7</td></tr></tbody></table><table-wrap-foot><fn><p>All values were calculated from at least two separate experiments with an error range of &#x000b1;30&#x00025;.</p></fn><fn><p><sup>a</sup><italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub> &#x0003d; (I<sub>3</sub>/I<sub>2</sub>)/(&#x000b5;M dNTP) normalized to a 10 min reaction with 10 fmol enzyme.</p></fn><fn><p><sup>b</sup><italic>f</italic><sub>ins</sub> &#x0003d; (<italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub>)<sub>incorrect</sub>/(<italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub>)<sub>correct</sub> as compared within each template set.</p></fn></table-wrap-foot></table-wrap><table-wrap id="gkh213tb2"><label>Table 2.</label><caption><title>Kinetics of insertion by the p140/p55 pol &#x003b3; complex opposite the BaP <italic>trans R</italic>, BaP <italic>trans S</italic>, BaP <italic>cis R</italic> and BaP <italic>cis S</italic> dA adducts in the sequence 3&#x02032;-&#x02026;TT<bold>A&#x0002a;</bold>GAC-5&#x02032;</title></caption><table frame="hsides" rules="groups" border="1" width="85%"><colgroup><col/><col/><col/><col/></colgroup><thead valign="bottom"><tr valign="top"><th valign="top">Adduct</th><th valign="top">dNTP</th><th valign="top"><italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub><sup>a</sup></th><th valign="top"><italic>f</italic><sub>ins</sub><sup>b</sup></th></tr></thead><tbody valign="top"><tr valign="top"><td valign="top">None</td><td valign="top">A:dATP</td><td valign="top">3.1 &#x000d7; 10<sup>&#x02013;1</sup></td><td valign="top">3.9 &#x000d7; 10<sup>&#x02013;3</sup></td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dTTP</td><td valign="top">82</td><td valign="top">1</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dCTP</td><td valign="top">1.9 &#x000d7; 10<sup>&#x02013;2</sup></td><td valign="top">2.3 &#x000d7; 10<sup>&#x02013;4</sup></td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dGTP</td><td valign="top">3 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">4 &#x000d7; 10<sup>&#x02013;5</sup></td></tr><tr valign="top"><td valign="top">BaP <italic>trans R</italic></td><td valign="top">A:dATP</td><td valign="top">1.6 &#x000d7; 10<sup>&#x02013;2</sup></td><td valign="top">8</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dTTP</td><td valign="top">2 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">1</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dCTP</td><td valign="top">ND</td><td valign="top">&#x000a0;</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dGTP</td><td valign="top">ND</td><td valign="top">&#x000a0;</td></tr><tr valign="top"><td valign="top">BaP <italic>trans S</italic></td><td valign="top">A:dATP</td><td valign="top">1.4 &#x000d7; 10<sup>&#x02013;2</sup></td><td valign="top">1.3</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dTTP</td><td valign="top">1.1 &#x000d7; 10<sup>&#x02013;2</sup></td><td valign="top">1</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dCTP</td><td valign="top">ND</td><td valign="top">&#x000a0;</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dGTP</td><td valign="top">ND</td><td valign="top">&#x000a0;</td></tr><tr valign="top"><td valign="top">BaP <italic>cis R</italic></td><td valign="top">A:dATP</td><td valign="top">2.2 x10<sup>&#x02013;2</sup></td><td valign="top">3.7</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dTTP</td><td valign="top">6 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">1</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dCTP</td><td valign="top">1 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">0.17</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dGTP</td><td valign="top">3 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">0.5</td></tr><tr valign="top"><td valign="top">BaP <italic>cis S</italic></td><td valign="top">A:dATP</td><td valign="top">3.4 &#x000d7; 10<sup>&#x02013;2</sup></td><td valign="top">6.8</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dTTP</td><td valign="top">5 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">1</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dCTP</td><td valign="top">2.9 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">0.6</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dGTP</td><td valign="top">7 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">1.4</td></tr></tbody></table><table-wrap-foot><fn><p>All values were calculated from at least two separate experiments with an error range of &#x000b1;30&#x00025;. ND, not detectable.</p></fn><fn><p><sup>a</sup><italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub> &#x0003d; (I<sub>3</sub>/I<sub>2</sub>)/(&#x000b5;M dNTP) normalized to a 10 min reaction with 10 fmol enzyme.</p></fn><fn><p><sup>b</sup><italic>f</italic><sub>ins</sub> &#x0003d; (<italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub>)<sub>incorrect</sub>/(<italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub>)<sub>correct</sub> as compared within each template set.</p></fn></table-wrap-foot></table-wrap><table-wrap id="gkh213tb3"><label>Table 3.</label><caption><title>Kinetics of insertion by the p140/p55 pol &#x003b3; complex opposite the BcPh <italic>cis R</italic> and BcPh <italic>cis S</italic> dA adducts in the sequence 3&#x02032;-&#x02026;TT<bold>A&#x0002a;</bold>GAC-5&#x02032;</title></caption><table frame="hsides" rules="groups" border="1" width="85%"><colgroup><col/><col/><col/><col/></colgroup><thead valign="bottom"><tr valign="top"><th valign="top">Adduct</th><th valign="top">dNTP</th><th valign="top"><italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub><sup>a</sup></th><th valign="top"><italic>f</italic><sub>ins</sub><sup>b</sup></th></tr></thead><tbody valign="top"><tr valign="top"><td valign="top">None</td><td valign="top">A:dATP</td><td valign="top">3.1 &#x000d7; 10<sup>&#x02013;1</sup></td><td valign="top">3.0 &#x000d7; 10<sup>&#x02013;3</sup></td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dTTP</td><td valign="top">106</td><td valign="top">1</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dCTP</td><td valign="top">1.6 &#x000d7; 10<sup>&#x02013;2</sup></td><td valign="top">1.5 &#x000d7; 10<sup>&#x02013;4</sup></td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dGTP</td><td valign="top">1 &#x000d7; 10<sup>&#x02013;2</sup></td><td valign="top">1 &#x000d7; 10<sup>&#x02013;4</sup></td></tr><tr valign="top"><td valign="top">BcPh <italic>cis R</italic></td><td valign="top">A:dATP</td><td valign="top">4 &#x000d7; 10<sup>&#x02013;2</sup></td><td valign="top">40</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dTTP</td><td valign="top">1 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">1</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dCTP</td><td valign="top">0.4 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">1.5 &#x000d7; 10<sup>&#x02013;4</sup></td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dGTP</td><td valign="top">0.9 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">0.9</td></tr><tr valign="top"><td valign="top">BcPh <italic>cis S</italic></td><td valign="top">A:dATP</td><td valign="top">5.4 &#x000d7; 10<sup>&#x02013;2</sup></td><td valign="top">9</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dTTP</td><td valign="top">2.6 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">1</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dCTP</td><td valign="top">3.5 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">1.4</td></tr><tr valign="top"><td valign="top">&#x000a0;</td><td valign="top">A:dGTP</td><td valign="top">3.3 &#x000d7; 10<sup>&#x02013;3</sup></td><td valign="top">1.3</td></tr></tbody></table><table-wrap-foot><fn><p>All values were calculated from at least two separate experiments with an error range &#x000b1;30&#x00025;.</p></fn><fn><p><sup>a</sup><italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub> &#x0003d; (I<sub>3</sub>/I<sub>2</sub>)/(&#x000b5;M dNTP) normalized to a 10 min reaction with 10 fmol enzyme.</p></fn><fn><p><sup>b</sup><italic>f</italic><sub>ins</sub> &#x0003d; (<italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub>)<sub>incorrect</sub>/(<italic>V</italic><sub>max</sub>/<italic>K</italic><sub>m</sub>)<sub>correct</sub> as compared within each template set.</p></fn></table-wrap-foot></table-wrap></sec><ack><sec><title>ACKNOWLEDGEMENTS</title><p>We thank Drs Matthew Longley and Kasia Bebenek for critical reading of this manuscript.</p></sec></ack><ref-list><title>REFERENCES</title><ref id="gkh213c1"><label>1.</label><citation citation-type="book"><name><surname>Thakker</surname><given-names>D.R.</given-names></name>, Yagi,H., Levin,W., Wood,A.W., Conney,A.H. and Jerina,D.M. (1985) Polycyclic aromatic hydrocarbons: Metabolic activation to ultimate carcinogens. In Anders,M.W. (ed.), <source>Bioactivation of Foreign Compounds</source>. <publisher-name>Academic Press</publisher-name>, New York, NY, pp. <fpage>177</fpage>&#x02013;<lpage>242</lpage>.</citation></ref><ref id="gkh213c2"><label>2.</label><citation citation-type="book"><name><surname>Jerina</surname><given-names>D.M.</given-names></name>, Yagi,H., Thakker,D.R., Sayer,J.M., van Bladeren,P.J., Lehr,R.E., Whalen,D.L., Levin,W., Chang,R.L., Wood,A.W. <italic>et al</italic>. (1984) Identification of the ultimate carcinogen metabolites of the polycyclic aromatic hydrocarbons: Bay-region (R,S)-diol-(S,R)-epoxides. In Caldwell,J. and Paulson,G.D. (eds.), <source>Foreign Compound Metabolism</source>. <publisher-name>Taylor &#x00026; Francis</publisher-name>, London, UK, pp. <fpage>257</fpage>&#x02013;<lpage>266</lpage>.</citation></ref><ref id="gkh213c3"><label>3.</label><citation citation-type="journal"><name><surname>Buening</surname><given-names>M.K.</given-names></name>, Wislocki,P.G., Levin,W., Yagi,H., Thakker,D.R., Akagi,H., Koreeda,M., Jerina,D.M. and Conney,A.H. (1978) Tumorigenicity of the optical enantiomers of the diastereomeric benzo&#x0005b;a&#x0005d;pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (&#x0002b;)-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo&#x0005b;a&#x0005d;pyrene. <source>Proc. Natl Acad. Sci. USA</source>, <volume>75</volume>, <fpage>5358</fpage>&#x02013;<lpage>5361</lpage>.<pub-id pub-id-type="pmid">281685</pub-id></citation></ref><ref id="gkh213c4"><label>4.</label><citation citation-type="journal"><name><surname>Levin</surname><given-names>W.</given-names></name>, Chang,R.L., Wood,A.W., Thakker,D.R., Yagi,H., Jerina,D.M. and Conney,A.H. (1986) Tumorigenicity of optical isomers of the diastereomeric bay-region 3,4-diol-1,2-epoxides of benzo(c)phenanthrene in murine tumor models. <source>Cancer Res.</source>, <volume>46</volume>, <fpage>2257</fpage>&#x02013;<lpage>2261</lpage>.<pub-id pub-id-type="pmid">3697970</pub-id></citation></ref><ref id="gkh213c5"><label>5.</label><citation citation-type="book"><name><surname>Jerina</surname><given-names>D.M.</given-names></name>, Chadha,A., Cheh,A.M., Schurdak,M.E., Wood,A.W. and Sayer,J.M. (1991) Covalent bonding of bay-region diol epoxides to nucleic acids. In Witmer,C.M., Snyder,R., Jollow,D.J., Kalf,G.F., Kocsis,J.J. and Sipes,I.G. (eds.), <source>Biological Reactive Intermediates IV. Molecular and Cellular Effects and Their Impact on Human Health</source>, Advances in Experimental Medicine and Biology no. 283. <publisher-name>Plenum Press</publisher-name>, New York, NY, pp. <fpage>533</fpage>&#x02013;<lpage>553</lpage>.</citation></ref><ref id="gkh213c6"><label>6.</label><citation citation-type="journal"><name><surname>Moriya</surname><given-names>M.</given-names></name>, Spiegel,S., Fernandes,A., Amin,S., Liu,T., Geacintov,N. and Grollman,A.P. (1996) Fidelity of translesional synthesis past benzo&#x0005b;a&#x0005d;pyrene diol epoxide-2&#x02032;-deoxyguanosine DNA adducts: marked effects of host cell, sequence context and chirality. <source>Biochemistry</source>, <volume>35</volume>, <fpage>16646</fpage>&#x02013;<lpage>16651</lpage>.<pub-id pub-id-type="pmid">8988000</pub-id></citation></ref><ref id="gkh213c7"><label>7.</label><citation citation-type="journal"><name><surname>Fernandes</surname><given-names>A.</given-names></name>, Liu,T., Amin,S., Geacintov,N.E., Grollman,A.P. and Moriya,M. (1998) Mutagenic potential of stereoisomeric bay region (&#x0002b;)- and (&#x02013;)-cis-anti-benzo&#x0005b;a&#x0005d;pyrene diol epoxide-N2-2&#x02032;-deoxyguanosine adducts in <italic>Escherichia coli</italic> and simian kidney cells. <source>Biochemistry</source>, <volume>37</volume>, <fpage>10164</fpage>&#x02013;<lpage>10172</lpage>.<pub-id pub-id-type="pmid">9665722</pub-id></citation></ref><ref id="gkh213c8"><label>8.</label><citation citation-type="journal"><name><surname>Wei</surname><given-names>S.J.</given-names></name>, Chang,R.L., Wong,C.Q., Bhachech,N., Cui,X.X., Hennig,E., Yagi,H., Sayer,J.M., Jerina,D.M., Preston,B.D. <italic>et al</italic>. (1991) Dose-dependent differences in the profile of mutations induced by an ultimate carcinogen from benzo&#x0005b;a&#x0005d;pyrene. <source>Proc. Natl Acad. Sci. USA</source>, <volume>88</volume>, <fpage>11227</fpage>&#x02013;<lpage>11230</lpage>.<pub-id pub-id-type="pmid">1763036</pub-id></citation></ref><ref id="gkh213c9"><label>9.</label><citation citation-type="journal"><name><surname>Sayer</surname><given-names>J.M.</given-names></name>, Kroth,H., Yagi,H., Kalena,G., Jerina,D.M., Ramos,L.A., Dipple,A., Pont&#x000e9;n,I. and Goodman,M.F. (2002) Mutational consequences on replication of M13 constructs containing isomeric diol epoxide adducts in <italic>E. coli</italic>. <source>Polycyclic Aromatic Compounds</source>, <volume>22</volume>, <fpage>871</fpage>&#x02013;<lpage>879</lpage>.</citation></ref><ref id="gkh213c10"><label>10.</label><citation citation-type="journal"><name><surname>Ramos</surname><given-names>L.A.</given-names></name>, Pont&#x000e9;n,I., Dipple,A., Kumar,S., Yagi,H., Sayer,J.M., Kroth,H., Kalena,G. and Jerina,D.M. (2002) Site-specific mutagenesis in <italic>Escherichia coli</italic> by N2-deoxyguanosine adducts derived from the highly carcinogenic fjord-region benzo&#x0005b;c&#x0005d;phenanthrene 3,4-diol 1,2-epoxides. <source>Chem. Res. Toxicol.</source>, <volume>15</volume>, <fpage>1619</fpage>&#x02013;<lpage>1626</lpage>.<pub-id pub-id-type="pmid">12482245</pub-id></citation></ref><ref id="gkh213c11"><label>11.</label><citation citation-type="journal"><name><surname>Backer</surname><given-names>J.M.</given-names></name> and Weinstein,I.B. (1980) Mitochondrial DNA is a major cellular target for a dihydrodiol-epoxide derivative of benzo&#x0005b;a&#x0005d;pyrene. <source>Science</source>, <volume>209</volume>, <fpage>297</fpage>&#x02013;<lpage>299</lpage>.<pub-id pub-id-type="pmid">6770466</pub-id></citation></ref><ref id="gkh213c12"><label>12.</label><citation citation-type="journal"><name><surname>Epstein</surname><given-names>S.S.</given-names></name> and Niskanen,E.E. (1967) Effects of tween 60 on benzo(a)pyrene uptake by <italic>Tetrahymena pyriformis</italic> and by isolated rat liver mitochondria. <source>Exp. Cell Res.</source>, <volume>46</volume>, <fpage>211</fpage>&#x02013;<lpage>214</lpage>.<pub-id pub-id-type="pmid">6025281</pub-id></citation></ref><ref id="gkh213c13"><label>13.</label><citation citation-type="journal"><name><surname>Greenblatt</surname><given-names>M.</given-names></name>, Rijhsinghani,K. and Nickles,P. (1967) Intracellular localization of 3-4 benzo(a)pyrene in <italic>Saccharomyces cerevisiae</italic>. <source>Proc. Soc. Exp. Biol. Med.</source>, <volume>126</volume>, <fpage>527</fpage>&#x02013;<lpage>529</lpage>.<pub-id pub-id-type="pmid">6079935</pub-id></citation></ref><ref id="gkh213c14"><label>14.</label><citation citation-type="journal"><name><surname>Cuccurullo</surname><given-names>L.</given-names></name> and Manocchio,G. (1972) Effects of benzo(a)pyrene on isolated rat liver mitochondria. <source>Experientia</source>, <volume>28</volume>, <fpage>311</fpage>&#x02013;<lpage>312</lpage>.<pub-id pub-id-type="pmid">5026446</pub-id></citation></ref><ref id="gkh213c15"><label>15.</label><citation citation-type="journal"><name><surname>Gill</surname><given-names>S.S.</given-names></name> and Hammock,B.D. (1981) Epoxide hydrolase activity in the mitochondrial fraction of mouse liver. <source>Nature</source>, <volume>291</volume>, <fpage>167</fpage>&#x02013;<lpage>168</lpage>.<pub-id pub-id-type="pmid">7194967</pub-id></citation></ref><ref id="gkh213c16"><label>16.</label><citation citation-type="journal"><name><surname>Salazar</surname><given-names>I.</given-names></name>, Tarrago-Litvak,L., Gil,L. and Litvak,S. (1982) The effect of benzo&#x0005b;a&#x0005d;pyrene on DNA synthesis and DNA polymerase activity of rat liver mitochondria. <source>FEBS Lett.</source>, <volume>138</volume>, <fpage>45</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="pmid">6279440</pub-id></citation></ref><ref id="gkh213c17"><label>17.</label><citation citation-type="journal"><name><surname>Niranjan</surname><given-names>B.G.</given-names></name>, Avadhani,N.G. and DiGiovanni,J. (1985) Formation of benzo&#x0005b;<italic>a</italic>&#x0005d;pyrene metabolites and DNA adducts catalyzed by a rat liver mitochondrial monooxygenase system. <source>Biochem. Biophys. Res. Commun.</source>, <volume>131</volume>, <fpage>935</fpage>&#x02013;<lpage>942</lpage>.<pub-id pub-id-type="pmid">2996532</pub-id></citation></ref><ref id="gkh213c18"><label>18.</label><citation citation-type="journal"><name><surname>Zhu</surname><given-names>H.</given-names></name>, Li,Y. and Trush,M.A. (1995) Characterization of benzo&#x0005b;a&#x0005d;pyrene quinone-induced toxicity to primary cultured bone marrow stromal cells from DBA/2 mice: potential role of mitochondrial dysfunction. <source>Toxicol. Appl. Pharmacol.</source>, <volume>130</volume>, <fpage>108</fpage>&#x02013;<lpage>120</lpage>.<pub-id pub-id-type="pmid">7530864</pub-id></citation></ref><ref id="gkh213c19"><label>19.</label><citation citation-type="journal"><name><surname>Perin-Roussel</surname><given-names>O.</given-names></name>, Perin,F., Barat,N., Plessis,M.J. and Zajdela,F. (1995) Interaction of 7H-dibenzo&#x0005b;c,g&#x0005d;carbazole and its organspecific derivatives with hepatic mitochondrial and nuclear DNA in the mouse. <source>Environ. Mol. Mutagen.</source>, <volume>25</volume>, <fpage>202</fpage>&#x02013;<lpage>210</lpage>.<pub-id pub-id-type="pmid">7737138</pub-id></citation></ref><ref id="gkh213c20"><label>20.</label><citation citation-type="journal"><name><surname>Backer</surname><given-names>J.M.</given-names></name> and Weinstein,I.B. (1982) Interaction of benzo(a)pyrene and its dihydrodiol-epoxide derivative with nuclear and mitochondrial DNA in C3H10T 1/2 cell cultures. <source>Cancer Res.</source>, <volume>42</volume>, <fpage>2764</fpage>&#x02013;<lpage>2769</lpage>.<pub-id pub-id-type="pmid">6282450</pub-id></citation></ref><ref id="gkh213c21"><label>21.</label><citation citation-type="journal"><name><surname>Stairs</surname><given-names>P.W.</given-names></name>, Guzelian,P.S. and Van Tuyle,G.C. (1983) Benzo&#x0005b;a&#x0005d;pyrene differentially alters mitochondrial and nuclear DNA synthesis in primary hepatocyte cultures. <source>Res. Commun. Chem. Pathol. Pharmacol.</source>, <volume>42</volume>, <fpage>95</fpage>&#x02013;<lpage>106</lpage>.<pub-id pub-id-type="pmid">6316439</pub-id></citation></ref><ref id="gkh213c22"><label>22.</label><citation citation-type="journal"><name><surname>Divi</surname><given-names>R.L.</given-names></name>, Beland,F.A., Fu,P.P., Von Tungeln,L.S., Schoket,B., Camara,J.E., Ghei,M., Rothman,N., Sinha,R. and Poirier,M.C. (2002) Highly sensitive chemiluminescence immunoassay for benzo&#x0005b;a&#x0005d;pyrene-DNA adducts: validation by comparison with other methods and use in human biomonitoring. <source>Carcinogenesis</source>, <volume>23</volume>, <fpage>2043</fpage>&#x02013;<lpage>2049</lpage>.<pub-id pub-id-type="pmid">12507927</pub-id></citation></ref><ref id="gkh213c23"><label>23.</label><citation citation-type="journal"><name><surname>Balansky</surname><given-names>R.</given-names></name>, Izzotti,A., Scatolini,L., D&#x02019;Agostini,F. and De Flora,S. (1996) Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs. <source>Cancer Res.</source>, <volume>56</volume>, <fpage>1642</fpage>&#x02013;<lpage>1647</lpage>.<pub-id pub-id-type="pmid">8603414</pub-id></citation></ref><ref id="gkh213c24"><label>24.</label><citation citation-type="journal"><name><surname>Shadel</surname><given-names>G.S.</given-names></name> and Clayton,D.A. (1997) Mitochondrial DNA maintenance in vertebrates. <source>Annu. Rev. Biochem.</source>, <volume>66</volume>, <fpage>409</fpage>&#x02013;<lpage>435</lpage>.<pub-id pub-id-type="pmid">9242913</pub-id></citation></ref><ref id="gkh213c25"><label>25.</label><citation citation-type="journal"><name><surname>Copeland</surname><given-names>W.C.</given-names></name> and Longley,M.J. (2003) DNA polymerase &#x003b3; in mitochondrial DNA replication and repair. <source>Sci. World J.</source>, <volume>3</volume>, <fpage>34</fpage>&#x02013;<lpage>44</lpage>.</citation></ref><ref id="gkh213c26"><label>26.</label><citation citation-type="journal"><name><surname>Longley</surname><given-names>M.J.</given-names></name>, Ropp,P.A., Lim,S.E. and Copeland,W.C. (1998) Characterization of the native and recombinant catalytic subunit of human DNA polymerase gamma: identification of residues critical for exonuclease activity and dideoxynucleotide sensitivity. <source>Biochemistry</source>, <volume>37</volume>, <fpage>10529</fpage>&#x02013;<lpage>10539</lpage>.<pub-id pub-id-type="pmid">9671525</pub-id></citation></ref><ref id="gkh213c27"><label>27.</label><citation citation-type="journal"><name><surname>Longley</surname><given-names>M.J.</given-names></name>, Prasad,R., Srivastava,D.K., Wilson,S.H. and Copeland,W.C. (1998) Identification of 5&#x02032;-deoxyribose phosphate lyase activity in human DNA polymerase gamma and its role in mitochondrial base excision repair <italic>in vitro</italic>. <source>Proc. Natl Acad. Sci. USA</source>, <volume>95</volume>, <fpage>12244</fpage>&#x02013;<lpage>12248</lpage>.<pub-id pub-id-type="pmid">9770471</pub-id></citation></ref><ref id="gkh213c28"><label>28.</label><citation citation-type="journal"><name><surname>Lim</surname><given-names>S.E.</given-names></name>, Longley,M.J. and Copeland,W.C. (1999) The mitochondrial p55 accessory subunit of human DNA polymerase gamma enhances DNA binding, promotes processive DNA synthesis and confers N-ethylmaleimide resistance. <source>J. Biol. Chem.</source>, <volume>274</volume>, <fpage>38197</fpage>&#x02013;<lpage>38203</lpage>.<pub-id pub-id-type="pmid">10608893</pub-id></citation></ref><ref id="gkh213c29"><label>29.</label><citation citation-type="journal"><name><surname>Frank</surname><given-names>E.G.</given-names></name>, Sayer,J.M., Kroth,H., Ohashi,E., Ohmori,H., Jerina,D.M. and Woodgate,R. (2002) Translesion replication of benzo&#x0005b;a&#x0005d;pyrene and benzo&#x0005b;c&#x0005d;phenanthrene diol epoxide adducts of deoxyadenosine and deoxyguanosine by human DNA polymerase iota. <source>Nucleic Acids Res.</source>, <volume>30</volume>, <fpage>5284</fpage>&#x02013;<lpage>5292</lpage>.<pub-id pub-id-type="pmid">12466554</pub-id></citation></ref><ref id="gkh213c30"><label>30.</label><citation citation-type="journal"><name><surname>Chiapperino</surname><given-names>D.</given-names></name>, Kroth,H., Kramarczuk,I.H., Sayer,J.M., Masutani,C., Hanaoka,F., Jerina,D.M. and Cheh,A.M. (2002) Preferential misincorporation of purine nucleotides by human DNA polymerase eta opposite benzo&#x0005b;a&#x0005d;pyrene 7,8-diol 9,10-epoxide deoxyguanosine adducts. <source>J. Biol. Chem.</source>, <volume>277</volume>, <fpage>11765</fpage>&#x02013;<lpage>11771</lpage>.<pub-id pub-id-type="pmid">11821420</pub-id></citation></ref><ref id="gkh213c31"><label>31.</label><citation citation-type="journal"><name><surname>Page</surname><given-names>J.E.</given-names></name>, Zajc,B., Oh-hara,T., Lakshman,M.K., Sayer,J.M., Jerina,D.M. and Dipple,A. (1998) Sequence context profoundly influences the mutagenic potency of trans-opened benzo&#x0005b;a&#x0005d;pyrene 7,8-diol 9,10-epoxide-purine nucleoside adducts in site-specific mutation studies. <source>Biochemistry</source>, <volume>37</volume>, <fpage>9127</fpage>&#x02013;<lpage>9137</lpage>.<pub-id pub-id-type="pmid">9636059</pub-id></citation></ref><ref id="gkh213c32"><label>32.</label><citation citation-type="journal"><name><surname>Kroth</surname><given-names>H.</given-names></name>, Yagi,H., Sayer,J.M., Kumar,S. and Jerina,D.M. (2001) O(6)-allyl protected deoxyguanosine adducts of polycyclic aromatic hydrocarbons as building blocks for the synthesis of oligonucleotides. <source>Chem. Res. Toxicol.</source>, <volume>14</volume>, <fpage>708</fpage>&#x02013;<lpage>719</lpage>.<pub-id pub-id-type="pmid">11409942</pub-id></citation></ref><ref id="gkh213c33"><label>33.</label><citation citation-type="journal"><name><surname>Christner</surname><given-names>D.F.</given-names></name>, Lakshman,M.K., Sayer,J.M., Jerina,D.M. and Dipple,A. (1994) Primer extension by various polymerases using oligonucleotide templates containing stereoisomeric benzo&#x0005b;a&#x0005d;pyrene-deoxyadenosine adducts. <source>Biochemistry</source>, <volume>33</volume>, <fpage>14297</fpage>&#x02013;<lpage>14305</lpage>.<pub-id pub-id-type="pmid">7524675</pub-id></citation></ref><ref id="gkh213c34"><label>34.</label><citation citation-type="journal"><name><surname>Page</surname><given-names>J.E.</given-names></name>, Pilcher,A.S., Yagi,H., Sayer,J.M., Jerina,D.M. and Dipple,A. (1999) Mutational consequences of replication of M13mp7L2 constructs containing cis-opened benzo&#x0005b;a&#x0005d;pyrene 7,8-diol 9, 10-epoxide-deoxyadenosine adducts. <source>Chem. Res. Toxicol.</source>, <volume>12</volume>, <fpage>258</fpage>&#x02013;<lpage>263</lpage>.<pub-id pub-id-type="pmid">10077488</pub-id></citation></ref><ref id="gkh213c35"><label>35.</label><citation citation-type="journal"><name><surname>Pont&#x000e9;n</surname><given-names>I.</given-names></name>, Sayer,J.M., Pilcher,A.S., Yagi,H., Kumar,S., Jerina,D.M. and Dipple,A. (2000) Factors determining mutagenic potential for individual <italic>cis</italic> and <italic>trans</italic> opened benzo&#x0005b;c&#x0005d;phenanthrene diol epoxide-deoxyadenosine adducts. <source>Biochemistry</source>, <volume>39</volume>, <fpage>4136</fpage>&#x02013;<lpage>4144</lpage>.<pub-id pub-id-type="pmid">10747805</pub-id></citation></ref><ref id="gkh213c36"><label>36.</label><citation citation-type="book"><name><surname>Sambrook</surname><given-names>J.</given-names></name>, Fritsch,E.F. and Maniatis,T. (1989) <source>Molecular Cloning: A Laboratory Manual, 2nd Edn.</source><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>, Cold Spring Harbor, NY.</citation></ref><ref id="gkh213c37"><label>37.</label><citation citation-type="journal"><name><surname>Longley</surname><given-names>M.J.</given-names></name>, Nguyen,D., Kunkel,T.A. and Copeland,W.C. (2001) The fidelity of human DNA polymerase gamma with and without exonucleolytic proofreading and the p55 accessory subunit. <source>J. Biol. Chem.</source>, <volume>276</volume>, <fpage>38555</fpage>&#x02013;<lpage>38562</lpage>.<pub-id pub-id-type="pmid">11504725</pub-id></citation></ref><ref id="gkh213c38"><label>38.</label><citation citation-type="journal"><name><surname>Boosalis</surname><given-names>M.S.</given-names></name>, Petruska,J. and Goodman,M.F. (1987) DNA polymerase insertion fidelity. Gel assay for site-specific kinetics. <source>J. Biol. Chem.</source>, <volume>262</volume>, <fpage>14689</fpage>&#x02013;<lpage>14696</lpage>.<pub-id pub-id-type="pmid">3667598</pub-id></citation></ref><ref id="gkh213c39"><label>39.</label><citation citation-type="journal"><name><surname>Mendelman</surname><given-names>L.V.</given-names></name>, Boosalis,M.S., Petruska,J. and Goodman,M.F. (1989) Nearest neighbor influences on DNA polymerase insertion fidelity. <source>J. Biol. Chem.</source>, <volume>264</volume>, <fpage>14415</fpage>&#x02013;<lpage>14423</lpage>.<pub-id pub-id-type="pmid">2474545</pub-id></citation></ref><ref id="gkh213c40"><label>40.</label><citation citation-type="journal"><name><surname>Lim</surname><given-names>S.E.</given-names></name> and Copeland,W.C. (2001) Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma. <source>J. Biol. Chem.</source>, <volume>276</volume>, <fpage>23616</fpage>&#x02013;<lpage>23623</lpage>.<pub-id pub-id-type="pmid">11319228</pub-id></citation></ref><ref id="gkh213c41"><label>41.</label><citation citation-type="journal"><name><surname>Johnson</surname><given-names>A.A.</given-names></name>, Ray,A.S., Hanes,J., Suo,Z., Colacino,J.M., Anderson,K.S. and Johnson,K.A. (2001) Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. <source>J. Biol. Chem.</source>, <volume>276</volume>, <fpage>40847</fpage>&#x02013;<lpage>40857</lpage>.<pub-id pub-id-type="pmid">11526116</pub-id></citation></ref><ref id="gkh213c42"><label>42.</label><citation citation-type="journal"><name><surname>Reardon</surname><given-names>J.E.</given-names></name> and Miller,W.H. (1990) Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5&#x02032;-triphosphate and 3&#x02032;-azido-3&#x02032;-deoxythymidine 5&#x02032;-triphosphate. <source>J. Biol. Chem.</source>, <volume>265</volume>, <fpage>20302</fpage>&#x02013;<lpage>20307</lpage>.<pub-id pub-id-type="pmid">1700787</pub-id></citation></ref><ref id="gkh213c43"><label>43.</label><citation citation-type="journal"><name><surname>Pinz</surname><given-names>K.G.</given-names></name>, Shibutani,S. and Bogenhagen,D.F. (1995) Action of mitochondrial DNA polymerase gamma at sites of base loss or oxidative damage. <source>J. Biol. Chem.</source>, <volume>270</volume>, <fpage>9202</fpage>&#x02013;<lpage>9206</lpage>.<pub-id pub-id-type="pmid">7721837</pub-id></citation></ref><ref id="gkh213c44"><label>44.</label><citation citation-type="journal"><name><surname>Vaisman</surname><given-names>A.</given-names></name>, Lim,S.E., Patrick,S.M., Copeland,W.C., Hinkle,D.C., Turchi,J.J. and Chaney,S.G. (1999) Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts. <source>Biochemistry</source>, <volume>38</volume>, <fpage>11026</fpage>&#x02013;<lpage>11039</lpage>.<pub-id pub-id-type="pmid">10460158</pub-id></citation></ref><ref id="gkh213c45"><label>45.</label><citation citation-type="journal"><name><surname>De Flora</surname><given-names>S.</given-names></name>, Balansky,R., Scatolini,L., Di Marco,C., Gasparini,L., Orlando,M. and Izzotti,A. (1996) Adducts to nuclear DNA and mitochondrial DNA as biomarkers in chemoprevention. <source>IARC Sci. Publ.</source>, <volume>139</volume>, <fpage>291</fpage>&#x02013;<lpage>301</lpage>.<pub-id pub-id-type="pmid">8923039</pub-id></citation></ref><ref id="gkh213c46"><label>46.</label><citation citation-type="journal"><name><surname>Lipinski</surname><given-names>L.J.</given-names></name>, Ross,H.L., Zajc,B., Sayer,J.M., Jerina,D.M. and Dipple,A. (1998) Effect of single benzo&#x0005b;a&#x0005d;pyrene diol epoxide-deoxyguanosine adducts on the action of DNA polymerases <italic>in vitro</italic>. <source>Int. J. Oncol.</source>, <volume>13</volume>, <fpage>269</fpage>&#x02013;<lpage>273</lpage>.<pub-id pub-id-type="pmid">9664121</pub-id></citation></ref><ref id="gkh213c47"><label>47.</label><citation citation-type="journal"><name><surname>Perlow</surname><given-names>R.A.</given-names></name> and Broyde,S. (2003) Extending the understanding of mutagenicity: structural insights into primer-extension past a benzo&#x0005b;a&#x0005d;pyrene diol epoxide-DNA adduct. <source>J. Mol. Biol.</source>, <volume>327</volume>, <fpage>797</fpage>&#x02013;<lpage>818</lpage>.<pub-id pub-id-type="pmid">12654264</pub-id></citation></ref><ref id="gkh213c48"><label>48.</label><citation citation-type="journal"><name><surname>Wallace</surname><given-names>D.C.</given-names></name> (1999) Mitochondrial diseases in man and mouse. <source>Science</source>, <volume>283</volume>, <fpage>1482</fpage>&#x02013;<lpage>1488</lpage>.<pub-id pub-id-type="pmid">10066162</pub-id></citation></ref><ref id="gkh213c49"><label>49.</label><citation citation-type="journal"><name><surname>Mita</surname><given-names>S.</given-names></name>, Rizzuto,R., Moraes,C.T., Shanske,S., Arnaudo,E., Fabrizi,G.M., Koga,Y., DiMauro,S. and Schon,E.A. (1990) Recombination via flanking direct repeats is a major cause of large-scale deletions of human mitochondrial DNA. <source>Nucleic Acids Res.</source>, <volume>18</volume>, <fpage>561</fpage>&#x02013;<lpage>567</lpage>.<pub-id pub-id-type="pmid">2308845</pub-id></citation></ref><ref id="gkh213c50"><label>50.</label><citation citation-type="journal"><name><surname>Marcelino</surname><given-names>L.A.</given-names></name>, Andre,P.C., Khrapko,K., Coller,H.A., Griffith,J. and Thilly,W.G. (1998) Chemically induced mutations in mitochondrial DNA of human cells: mutational spectrum of N-methyl-N&#x02032;-nitro-N-nitrosoguanidine. <source>Cancer Res.</source>, <volume>58</volume>, <fpage>2857</fpage>&#x02013;<lpage>2862</lpage>.<pub-id pub-id-type="pmid">9661902</pub-id></citation></ref></ref-list></back></article> 